Free Trial
NYSEAMERICAN:ASXC

Asensus Surgical (ASXC) Stock Price, News & Analysis

Asensus Surgical logo
$0.35 0.00 (0.00%)
As of 08/22/2024

About Asensus Surgical Stock (NYSEAMERICAN:ASXC)

Key Stats

Today's Range
$0.35
$0.35
50-Day Range
$0.35
$0.35
52-Week Range
$0.17
$0.40
Volume
N/A
Average Volume
2.03 million shs
Market Capitalization
$94.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.

Receive ASXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Asensus Surgical and its competitors with MarketBeat's FREE daily newsletter.

ASXC Stock News Headlines

Missed Nvidia? Trump’s Trade War Could Create a Bigger Winner
Missed out on Nvidia? Don’t worry — a bigger AI opportunity may be emerging right now, thanks to Trump’s newly announced tariffs. One under-the-radar U.S. semiconductor stock just gained a major edge over its foreign rivals. With demand poised to skyrocket, this chipmaker could be perfectly positioned to ride the next wave of AI growth. Shares are still flying low — but not for long.
See More Headlines

ASXC Stock Analysis - Frequently Asked Questions

Asensus Surgical's stock was trading at $0.3479 at the beginning of 2025. Since then, ASXC stock has increased by 0.0% and is now trading at $0.3479.
View the best growth stocks for 2025 here
.

Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) posted its quarterly earnings data on Wednesday, November, 3rd. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by $0.01. The business earned $2.57 million during the quarter, compared to analyst estimates of $1.02 million. Asensus Surgical had a negative net margin of 902.25% and a negative trailing twelve-month return on equity of 184.10%.

Shares of ASXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Asensus Surgical investors own include Digital Turbine (APPS), CrowdStrike (CRWD), ChargePoint (CHPT), SoFi Technologies (SOFI) and Tesla (TSLA).

Company Calendar

Last Earnings
11/03/2021
Today
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NYSEAMERICAN:ASXC
CIK
N/A
Employees
170
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$78.43 million
Net Margins
-902.25%
Pretax Margin
-899.16%

Debt

Sales & Book Value

Annual Sales
$8.58 million
Price / Cash Flow
N/A
Book Value
$0.13 per share
Price / Book
2.68

Miscellaneous

Free Float
264,516,000
Market Cap
$94.74 million
Optionable
Not Optionable
Beta
1.37
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NYSEAMERICAN:ASXC) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners